Full Text
Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States

Abstract

Authors

F Rencz L Gulácsi M Péntek P Baji

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×